Anavex2-73 oral liquid    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
156Rett syndrome1

156. Rett syndrome    [ 36 clinical trials,   49 drugs,   (DrugBank: 19 drugs),   77 drug target genes,   112 drug target pathways]
Searched query = "Rett syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 36 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04304482
(ClinicalTrials.gov)
July 1, 20208/3/2020ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeA Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett SyndromeRett SyndromeDrug: ANAVEX2-73 oral liquid;Drug: Placebo oral liquidAnavex Life Sciences Corp.Anavex Australia Pty Ltd.;Anavex Germany GmbHRecruiting5 Years18 YearsFemale69Phase 2;Phase 3Australia